Givaudan Valuation Multiples

Givaudan is valued at $44B as of October 2026, a 5.2x revenue multiple. In the last 12 months, Givaudan revenue was $9.4B and Givaudan EBITDA was $2.2B.

Givaudan Overview

About Givaudan

Spun off from Roche in 2000, Givaudan is one of the world's leading flavor and fragrance manufacturers, with a presence in more than 80 countries. It sources more than 11,000 different ingredients from over 100 countries. The company serves end consumer markets with fragrances for personal, home, and laundry care brands, including prestige perfumes. In flavors, customers are in beverages, savory, snacks, sweet goods, and dairy. Givaudan has nearly 10,000 employees, and its perfumery team is the largest in the industry.


Founded

1768

HQ

Switzerland

Employees

17.6K

Financials (LTM)

Revenue: $9.4B
EBITDA: $2.2B

EV

$49B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Givaudan Financials

Givaudan reported last 12-month revenue of $9.4B and EBITDA of $2.2B.

In the same LTM period, Givaudan generated $4.1B in gross profit, $2.2B in EBITDA, and $1.3B in net income.

Revenue (LTM)


Givaudan P&L

In the most recent fiscal year, Givaudan reported revenue of $9B and EBITDA of $2.1B.

Givaudan is profitable as of last fiscal year, with gross margin of 44%, EBITDA margin of 24%, and net margin of 14%.

See analyst estimates for Givaudan
LTMLast FY202320242025202620272028
Revenue$9.4B$9B$8.5B$9.1B$9B
Gross Profit$4.1B$3.9B$3.5B$4B$3.9B
Gross Margin44%44%41%44%44%
EBITDA$2.2B$2.1B$1.8B$2.2B$2.1B
EBITDA Margin23%24%21%24%24%
EBIT Margin18%18%16%19%18%
Net Profit$1.3B$1.3B$1.1B$1.3B$1.3B
Net Margin14%14%13%15%14%
Net Debt-$4B---

Financial data powered by Morningstar, Inc.

Givaudan Stock Performance

Givaudan has current market cap of $44B, and enterprise value of $49B.

Market Cap Evolution


Givaudan's stock price is $4,734.84.

Givaudan share price increased by 15.5% in the last 30 days, and by 15.1% in the last year.

Givaudan has an EPS (earnings per share) of $140.31.

See more trading valuation data for Givaudan
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$49B$44B0.0%15.5%18.1%15.1%$140.31

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Givaudan Valuation Multiples

Givaudan trades at 5.2x EV/Revenue multiple, and 22.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Givaudan

EV / Revenue (LTM)


Givaudan Financial Valuation Multiples

As of October 18, 2026, Givaudan has market cap of $44B and EV of $49B.

Givaudan has a P/E ratio of 33.8x.

LTMLast FY202320242025202620272028
EV/Revenue5.2x5.5x5.8x5.4x5.5x
EV/EBITDA22.4x23.1x27.4x22.4x23.1x
EV/EBIT28.5x29.7x36.2x28.7x29.7x
EV/Gross Profit12.0x12.5x14.1x12.3x12.5x
P/E33.8x33.7x39.8x32.6x33.7x
EV/FCF39.7x36.3x36.5x30.1x36.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Givaudan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Givaudan Margins & Growth Rates

Givaudan grew revenue by 4% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, Givaudan reported gross margin of 44%, EBITDA margin of 24%, and net margin of 14%.

See estimated margins and future growth rates for Givaudan

Givaudan Margins

Last FY202420252026202720282029
Gross Margin44%44%44%44%
EBITDA Margin24%24%24%23%
EBIT Margin18%19%18%18%
Net Margin14%15%14%14%
FCF Margin15%18%15%13%

Givaudan Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%7%(1%)4%
Gross Profit Growth4%15%(2%)4%
EBITDA Growth2%22%(3%)2%
EBIT Growth2%26%(3%)2%
Net Profit Growth(2%)22%(3%)(2%)
FCF Growth(14%)21%(17%)(14%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Givaudan Operational KPIs

Givaudan's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Givaudan's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Givaudan's Rule of X is 32% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Givaudan
LTMLast FY202320242025202620272028
Rule of 4028%27%---
Bessemer Rule of X34%32%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue9%13%13%13%13%
G&A Expenses to Revenue3%3%3%3%3%
R&D Expenses to Revenue8%7%8%8%7%
Opex to Revenue-25%25%25%25%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Givaudan Competitors

Givaudan competitors include Danone, Grupo Nutresa, Hindustan Unilever, Sysco, Keurig Dr Pepper, Coca-Cola Europacific Partners, BASF, SABIC, Sika and Hershey.

Most Givaudan public comparables operate across Food & Beverages and Chemicals.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Danone$31B$4.6B1.8x1.7x11.8x9.7x
Grupo Nutresa$6.5B$938M7.0x-48.1x-
Hindustan Unilever$6.7B$1.6B6.9x6.6x29.1x28.2x
Sysco$85B$4.1B0.6x0.6x13.0x11.9x
Keurig Dr Pepper$17B$4.2B5.1x3.5x20.1x13.1x
Coca-Cola Europacific Partners$23B$4.1B2.6x2.5x14.9x14.0x
BASF$67B$8B1.1x1.0x9.0x8.6x
SABIC$31B$3.9B1.4x1.5x11.0x10.1x

This data is available for Pro users. Sign up to see all Givaudan competitors and their valuation data.

Start Free Trial

Acquisitions by Givaudan

Givaudan has acquired 19 companies to date.

Last acquisition by Givaudan was on June 4th 2026. Givaudan acquired Eurofragance for $235M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Givaudan

Eurofragance
Belle Aire Creations
Vollmens Fragrances
DDW The Color House
Description
Eurofragance is a family-owned international company. The firm designs and produces fragrances for perfumery, personal care, household products, and air fresheners.
Belle Aire Creations is a fragrance and odor control company blending perfumery with science to produce custom scents and air care solutions.
Vollmens Fragrances is a São Paulo-based Brazilian fragrance manufacturer serving fine perfumes, personal care, home care, fabric care, and pet products. Its portfolio includes custom formulations from award-winning perfumers and Voll Caps Care microencapsulation for extended scent release in hair care. The company exhibits multi-station sensory booths at events like in-cosmetics Latin America to support clients from development to market launch.
DDW The Color House supplies natural colors, caramel colors, burnt sugars, and fruit-vegetable browns to food and beverage manufacturers. Established over 140 years ago, the company adapted from malt provision during prohibition to dominate caramel production, with facilities in the United Kingdom, China, eSwatini, Brazil, and Ireland.
HQ CountrySpainUnited StatesBrazilUnited States
HQ City
Barcelona
-
São Paulo
Louisville, KY
Deal Date4 Jun 20262 Dec 202527 Jun 202511 Oct 2021
Valuation$235Mundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Givaudan acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Givaudan

Givaudan has invested in 4 companies to date.

Latest investment by Givaudan was on July 6th 2026. Givaudan invested in Microcaps in their Strategic investment round.

See VC round multiples

Latest Investments by Givaudan

Microcaps
Nanovetores
Arcaea
SensorWake
Description
Microcaps is a Switzerland-based developer of microfluidic technology for microcapsule production. The company manufactures uniform particles for drug delivery, food encapsulation, and cosmetics with precise size control from 10-1000 microns. Headquartered in Zurich, Microcaps offers automated systems scaling from lab to ton-per-year output. Spin-off from ETH Zurich in 2019, it partners with pharma firms for personalized medicine formulations.
Nanovetores is a Brazilian family-owned company that develops nano and microencapsulated active ingredients for cosmetics. It was founded in 2009 by Betina Giehl Zanetti Ramos and Ricardo Henrique Ramos and is based in Florianopolis. Its technology stabilises actives such as hyaluronic acid, glycolic acid, salicylic acid and kojic acid for skin care, hair care and fragrance products. Manufacturing follows green chemistry principles, is water-based and uses no organic solvents. The company employed about 56 people and sells its award-winning ingredients to beauty brands internationally. Its platform could also be applied in food and pharmaceuticals, and the company supplies samples and technical support to formulators. The Criatec fund invested in 2012.
Arcaea is a Boston-based biotechnology company engineering novel ingredients for skincare and cosmetics via synthetic biology. The firm sequences DNA to ferment microbial strains producing peptides and lipids mimicking human skin components. Arcaea develops products like hydrating serums and anti-aging creams sold through Sephora and Ulta. Partnerships with contract manufacturers enable scalable production of clean-label formulations free from synthetics. Launched in 2021, it targets expressive biology for personalized beauty routines.
SensorWake is a French company manufacturing olfactory alarm clocks that wake users with scents like coffee or ocean breeze. The Nabla model offers 8 aroma cartridges compatible with USB charging and smartphone apps. Distributed in Europe and the United States, SensorWake targets light sleepers avoiding sound-based alarms. Founded in 2014, it promotes gentle awakenings through patented diffusion technology.
HQ CountrySwitzerlandBrazilUnited StatesFrance
HQ City
Zurich
Florianopolis
Boston, MA
Nantes
Deal Date6 Jul 202626 Jan 202227 Oct 20211 Jun 2017
RoundStrategic investmentSecondarySeries ASeed
Raisedundisclosedundisclosed$78M$2M
InvestorsGivaudanGivaudanGivaudan; Wittington Ventures; Cascade Investment; Viking Global Investors; CHANELPays de la Loire Participations; FaDièse; Givaudan; BNP Paribas Développement
Valuationundisclosedundisclosedundisclosed$5M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Givaudan investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Givaudan

When was Givaudan founded?Givaudan was founded in 1768.
Where is Givaudan headquartered?Givaudan is headquartered in Switzerland.
How many employees does Givaudan have?As of today, Givaudan has over 17K employees.
Is Givaudan publicly listed?Yes, Givaudan is a public company listed on SIX Swiss Exchange.
What is the stock symbol of Givaudan?Givaudan trades under GIVN ticker.
When did Givaudan go public?Givaudan went public in 2008.
Who are competitors of Givaudan?Givaudan main competitors include Danone, Grupo Nutresa, Hindustan Unilever, Sysco, Keurig Dr Pepper, Coca-Cola Europacific Partners, BASF, SABIC, Sika, Hershey.
What is the current market cap of Givaudan?Givaudan's current market cap is $44B.
What is the current revenue of Givaudan?Givaudan's last 12 months revenue is $9.4B.
What is the current revenue growth of Givaudan?Givaudan revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Givaudan?Current revenue multiple of Givaudan is 5.2x.
What is the current EBITDA of Givaudan?Givaudan's last 12 months EBITDA is $2.2B.
What is Givaudan's EBITDA margin?Givaudan's last 12 months EBITDA margin is 23%.
What is the current EV/EBITDA multiple of Givaudan?Current EBITDA multiple of Givaudan is 22.4x.
What is the current FCF of Givaudan?Givaudan's last 12 months FCF is $1.2B.
What is Givaudan's FCF margin?Givaudan's last 12 months FCF margin is 13%.
What is the current EV/FCF multiple of Givaudan?Current FCF multiple of Givaudan is 39.7x.
How many companies Givaudan has acquired to date?As of October 2026, Givaudan has acquired 19 companies.
What was the largest acquisition by Givaudan?$1.4B acquisition of Naturex on 19th September 2018 was the largest M&A Givaudan has done to date.
What companies Givaudan acquired?Givaudan acquired Naturex, Ungerer & Company, Spicetec Flavors & Seasonings, Eurofragance, Expressions Parfumees SAS, Drom Fragrances, Vika BV, Active International, Induchem, B.Kolor, and 9 other companies.
In how many companies Givaudan has invested to date?As of October 2026, Givaudan has invested in 4 companies.
What was the last Givaudan investment?On 6th July 2026 Givaudan invested in Microcaps, participating in a Strategic investment round.
In what companies Givaudan invested in?Givaudan invested in Arcaea, SensorWake, Microcaps, and Nanovetores.

See public comps similar to Givaudan

Lists including Givaudan

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial